Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-005172
Filing Date
2020-01-28
Accepted
2020-01-28 16:54:19
Documents
1
Period of Report
2020-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6523
  Complete submission text file 0001209191-20-005172.txt   7921
Mailing Address
Business Address
SANDELL SCOTT D (Reporting) CIK: 0001237289 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 20555206

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)